U.S. Blood Pathogen Reduction Markets Push toward Zero-Risk Blood Supply Drives Market Adoption “The growing patient demand for a zero risk blood supply is driving enormous investment into development of pathogen reduction solutions by both small biotechnology firms and large medical device manufacturers.” Discovery and Diagnostics Group Analyst Team Frost & Sullivan

Patient demand for zero-risk blood supply is driving large investments into improved pathogen reduction technologies Efficacy and safety data of pathogen inactivation systems from both research labs and clinical settings have been promising Market is essentially empty of competitors as, currently, only older technologies exist to inactivate pathogens in blood supply Adoption by physicians and blood bankers is already being debated intensively Industry Trends

Frost & Sullivan provides: Detailed insights into recent developments and trends Drivers, restraints, challenges, and strategic recommendations Analyst insights on ‘hot topics’ and emerging applications in the Pathogen Reduction Market Market sizing and competitive analysis Market forecasts and opportunity analysis End user analysis within each report Key Features

Global Coverage: U.S., Europe, Japan Proven methodology encompassing extensive primary and secondary data and research Focused information and strategies that cover business and technology issues Credible data and analysis highlighting industry dynamics Winning strategies to help you create precise business plans What We Offer

Current Market Participants Find out how you compare to the competition Assess current and future drivers and restraints Determine and exploit new market share opportunities New Entrants Analyze challenges associated with the industry Calculate time scales for strategy implementation Position yourself to capitalize on the market’s unmet needs Investment Community Analyze long-term strategies of pathogen reduction companies Determine which participants will outperform the competition Assess attractiveness of investing in pathogen reduction market Who Will Benefit?

Red Blood Cell Market Data Plasma and Platelet Market Data Biologics Market Data Analysis of Competitive Factors What’s Included

Abbott Laboratories Altchem Corp. Amersham Biosciences Baxter Fenwal Biopure Corp. Cerus Corp. Chiron Corp. Gambro BCT Gambro Pathogen Reduction Technologies, Inc. Haemonetics Corp. Independent Consultant Co., Ltd. Maxwell Technologies Medtronic, Inc. National Blood Data Resource Center New York Blood Center Northfield Laboratories, Inc. Pall Corp. Polycom, Inc. Roche Diagnostics Sangart, Inc. V.I. Technologies, Inc. Key Market Participants

Call toll free 877 G O F ROST ( ) Fax toll free Visit For More Information